VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V.
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1367401
AMSTERDAM, P7
Position in TMO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$216,629,067
-$41,880,382 QoQ
Shares Held
440,724
-1.2% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
2.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 23.931303945326327.ToString("F0")%
Shared 0.ToString("F0")%
None 76.06869605467367.ToString("F0")%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. holds $403,398,357 across 6 Diagnostics & Research names. TMO ranks #1 (53.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
440,724 | $216,629,067 | |
| 2 | ICLR |
Icon PLC
|
918,713 | $101,664,780 | |
| 3 | DGX |
Quest Diagnostics Inc
|
256,298 | $50,229,282 | |
| 4 | QGEN |
Qiagen N.V.
|
431,253 | $17,267,370 | |
| 5 | DHR |
Danaher Corp /De/
|
52,537 | $9,961,015 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
44,839 | $7,646,843 |
All Filings in TMO
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $216,629,067 | 440,724 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $258,509,449 | 446,129 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $250,883,385 | 517,264 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $209,971,110 | 517,859 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $159,985,366 | 321,514 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $161,258,294 | 309,975 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $133,951,333 | 216,550 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $117,739,230 | 212,910 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $107,024,009 | 184,140 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $85,732,139 | 161,518 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $34,907,507 | 68,964 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $34,564,372 | 66,247 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $35,437,533 | 61,484 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $35,274,447 | 64,055 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $13,066,228 | 25,762 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,076,928 | 25,911 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $14,898,555 | 25,224 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $17,063,995 | 25,574 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $13,180,583 | 23,070 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,142,650 | 16,141 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,234,750 | 9,279 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,317,255 | 4,975 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||